1-855-378-42281-855-378-4228
One of the outpatient rehab alternatives for clients in Stout battling with opioid dependence and addiction is called opioid maintenance therapy. Licensed clinics and doctors are certified to dispense certain medications to opioid dependent individuals, many of which are opioid-based themselves and are addiction. In low enough amounts however, the client does not experience high feelings but also doesn't experience acute cravings and is not in opioid withdrawal. Methadone is the first medication used for this reason, but there are other options currently to pick from.
Methadone is an opiate and is meant to be taken at an outpatient medical center licensed to dispense the med, that is taken daily in liquid or pill form. The cost of the drug is about one hundred and fifty dolloars a month. Buprenorphine is also an opiate based med, and is in pill form often taken one day on, one day off. But different from Methadone which can only be dispensed in structured medical centers, Buprenorphine can be prescribed and administered in doctor's offices. The price monthly of buprenorphine is approximately $300 monthly for the generic version of the drug. There is also a version of buprenorphine that contains naloxone, which is a drug that reverses the effects of opiates. A person taking this version of the drug, also known as Suboxone, would find it more difficult to get high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and is priced around $450 monthly. Naltrexone is an additional med used in opioid maintenance therapy, but unlike the other drugs mentioned here it's an opiate blocker and is not an opiate. There is an option to take this medication as a monthly injection, and that is called Vivitrol. As an opioid blocker, it prevents someone from feeling high from opioids, and in turn lowers the risk associated with relapse. This daily shot costs in the range of $1000 to $1200 a month.
For All Drug and Alcohol Rehabilitation Facilities In Stout, Click Here.
